Literature DB >> 22889128

Immortalized functional endothelial progenitor cell lines from umbilical cord blood for vascular tissue engineering.

Praveen K Sobhan1, Mahendra Seervi, Jeena Joseph, Saneesh Varghese, Prakash Rajappan Pillai, Divya Mundackal Sivaraman, Jackson James, Roshin Elizabeth George, K E Elizabeth, T R Santhoshkumar, M Radhakrishna Pillai.   

Abstract

Endothelial progenitor cells (EPCs) play a significant role in multiple biological processes such as vascular homeostasis, regeneration, and tumor angiogenesis. This makes them a promising cell of choice for studying a variety of biological processes, toxicity assays, biomaterial-cell interaction studies, as well as in tissue-engineering applications. In this study, we report the generation of two clones of SV40-immortalized EPCs from umbilical cord blood. These cells retained most of the functional features of mature endothelial cells and showed no indication of senescence after repeated culture for more than 240 days. Extensive functional characterization of the immortalized cells by western blot, flow cytometry, and immunofluorescence studies substantiated that these cells retained their ability to synthesize nitric oxide, von Willebrand factor, P-Selectin etc. These cells achieved unlimited proliferation potential subsequent to inactivation of the cyclin-dependent kinase inhibitor p21, but failed to form colonies on soft agar. We also show their enhanced growth and survival on vascular biomaterials compared to parental cultures in late population doubling. These immortalized EPCs can be used as a cellular model system for studying the biology of these cells, gene manipulation experiments, cell-biomaterial interactions, as well as a variety of tissue-engineering applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889128      PMCID: PMC3483052          DOI: 10.1089/ten.TEC.2011.0482

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  48 in total

Review 1.  Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.

Authors:  Ioannis Andreou; Dimitris Tousoulis; Costas Tentolouris; Charalambos Antoniades; Christodoulos Stefanadis
Journal:  Atherosclerosis       Date:  2006-07-24       Impact factor: 5.162

2.  In vivo vasculogenic potential of human blood-derived endothelial progenitor cells.

Authors:  Juan M Melero-Martin; Zia A Khan; Arnaud Picard; Xiao Wu; Sailaja Paruchuri; Joyce Bischoff
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

Review 3.  Circulating endothelial cells and endothelial progenitor cells: two sides of the same coin, or two different coins?

Authors:  Andrew D Blann; Adolf Pretorius
Journal:  Atherosclerosis       Date:  2006-02-20       Impact factor: 5.162

4.  Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

Authors:  Yuval Shaked; Alessia Ciarrocchi; Marcela Franco; Christina R Lee; Shan Man; Alison M Cheung; Daniel J Hicklin; David Chaplin; F Stuart Foster; Robert Benezra; Robert S Kerbel
Journal:  Science       Date:  2006-09-22       Impact factor: 47.728

Review 5.  Endothelial cell senescence.

Authors:  J D Erusalimsky; D J Kurz
Journal:  Handb Exp Pharmacol       Date:  2006

6.  Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway.

Authors:  E J Chapman; C D Hurst; E Pitt; P Chambers; J S Aveyard; M A Knowles
Journal:  Oncogene       Date:  2006-04-17       Impact factor: 9.867

Review 7.  Endothelial progenitor cell senescence--is there a role for estrogen?

Authors:  Toshio Imanishi; Hiroto Tsujioka; Takashi Akasaka
Journal:  Ther Adv Cardiovasc Dis       Date:  2009-12-04

Review 8.  Cyclin-dependent kinase inhibitor p16(INK4a) and telomerase may co-modulate endothelial progenitor cells senescence.

Authors:  De-Guang Yang; Ling Liu; Xiao-Yan Zheng
Journal:  Ageing Res Rev       Date:  2008-02-12       Impact factor: 10.895

9.  Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves.

Authors:  Virna L Sales; Bret A Mettler; George C Engelmayr; Elena Aikawa; Joyce Bischoff; David P Martin; Alexis Exarhopoulos; Marsha A Moses; Frederick J Schoen; Michael S Sacks; John E Mayer
Journal:  Tissue Eng Part A       Date:  2010-01       Impact factor: 3.845

10.  Postnatal neovascularization by endothelial progenitor cells immortalized with the simian virus 40T antigen gene.

Authors:  Hui-Ying Qiu; Yoshihiro Fujimori; Keisuke Nishioka; Nobuko Yamaguchi; Tomoko Hashimoto-Tamaoki; Ayako Sugihara; Nobuyuki Terada; Noritoshi Nagaya; Munetake Kanda; Naoya Kobayashi; Noriaki Tanaka; Karen A Westerman; Philippe Leboulch; Hiroshi Hara
Journal:  Int J Oncol       Date:  2006-04       Impact factor: 5.650

View more
  3 in total

1.  Activity of the human immortalized endothelial progenitor cell line HEPC-CB.1 supporting in vitro angiogenesis.

Authors:  Aneta Kantor; Agnieszka Krawczenko; Aleksandra Bielawska-Pohl; Danuta Duś; Catherine Grillon; Claudine Kieda; Karol Charkiewicz; Maria Paprocka
Journal:  Mol Biol Rep       Date:  2020-07-23       Impact factor: 2.316

Review 2.  A prospect of cell immortalization combined with matrix microenvironmental optimization strategy for tissue engineering and regeneration.

Authors:  Yiming Wang; Song Chen; Zuoqin Yan; Ming Pei
Journal:  Cell Biosci       Date:  2019-01-05       Impact factor: 7.133

3.  Atorvastatin Protects Against Cerebral Aneurysmal Degenerative Pathology by Promoting Endothelial Progenitor Cells (EPC) Mobilization and Attenuating Vascular Deterioration in a Rat Model.

Authors:  Huijie Wei; Mengchen Yang; Kai Yu; Wang Dong; Wang Liang; Zengguang Wang; Rongcai Jiang; Jianning Zhang
Journal:  Med Sci Monit       Date:  2019-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.